本期关注：医药板块估值溢价屡创历史新高；结束“回头看”，各省基本药物增补目录陆续出台。投资建议：建议关注1.具有中药独家品种、或品牌价值优势的企业，如同仁堂、天士力、华润三九等；2.受益于新医改鼓励民营资本办医的通策医疗、迪安诊断和GMP升级改造的新华医疗；3.有创新能力及一定业绩支撑的生物制品公司，如长春高新、通化东宝和双鹭药业等；4.化学药关注具强大创新及盈利能力的龙头企业恒瑞医药、人福医药以及行业新贵恩华药业、海思科等；5.医药流通关注全国及区域性龙头企业，如上海医药、国药股份和瑞康医药等。6.产品向制剂成功转型的华海药业以及契合政策导向、产品质量占据绝对领先的药用辅料龙头尔康制药。

报告从行业事件分析、竞争环境、医药研发、竞争对手、行业数据等几个方面进行了分析评论。

报告从行业事件分析、竞争环境、医药研发、竞争对手、行业数据等几个方面进行了分析评论。

报告从产业动态、产业分析、技术趋势、企业跟踪、地方动向等几个方面进行了分析评论。

报告从政策环境、市场行情、厂商动态、科技研发、国际资讯、行业数据、分析评论等几个方面进行了分析评论。

The active pharmaceutical ingredients also known as commodity bulk drugs are the substances that are used in the manufacturing of a drug or any other medicinal product, that when used in the production of a drug becomes an active ingredient of the drug.The active substance is used for the therapeutic effect in the drug and the efficacy of a drug is determined by the concentration and composition of the API. The APIs are used in various stages of pharmaceutical development such as sample testing, general analytical testing and development of methods. The ingredients are used as good manufacturing practice(GMP) in clinical trials and as source materials in manufactured marketed drugs.

The global animal healthcare industry is one of the potential industries in the world which comprises of segments such as pharmaceuticals, vaccines, medical feeds and farm and companion animals. The pharmaceuticals segment is the major contributor to the global animal health care industry followed by the vaccine and the medical feed segment.

The US pharmaceutical industry is the world's largest pharmaceutical industry with market size of USD 318.5 billion in 2010. The pharmaceutical industry mainly consists of drugs and biologics which aid in preventing, diagnosing, improving, treating and curing diseases. Chemically derived drugs are manufactured as pills, tablets, vials, ointments, powders, capsules, suspensions and solutions, while biologics are offered in the form of therapeutic proteins, vaccines, tissues, blood and blood components, anti-sera and others.

Historically, structure of the Japanese pharmaceutical industry was "closed" in nature which means only domestic companies had the control over the market but in later stages government introduced liberal policies by allowing foreign firms to setup distribution or R&D units in the country. Before amendment, there was a monopoly of domestic players in the market but now this trend is changing with large international pharmaceutical firms entering in the market and acquiring small domestic firms.

开发抗菌药物分级管理系统，进一步加强医院抗菌药物临床应用管理。方法：自主研发抗菌药物分级管理系统，并将其应用到抗菌药物的日常管理和监控中。结果：该系统基于Browser/Server的3层结构设计，具有人员及权限管理、用户信息维护、基础数据维护、全院抗菌药物指标统计、住院抗菌药物追踪及门诊抗菌药物追踪模块。该系统应用前、后3个月，我院抗菌药物使用强度由54.19 DDDs/100人/天下降至39.27 DDDs/100人/天，住院患者使用抗菌药物百分率由49.34%下降至37.06%，使用抗菌药物的出院患者病原学送检率由14.10%上升至32.24%，门诊抗菌药物处方比例由20.30%下降至14.87%。结论：抗菌药物分级管理系统可作为医院抗菌药物合理使用的工具。